Published in Gene Therapy Weekly, November 14th, 2002
"The human cyclin T1 (hCycT1) protein from the positive transcription elongation factor b (P-TEFb) binds the transactivator Tat and the transactivation response (TAR) RNA stem loop from human immunodeficiency virus type 1 (HIV)," explained Koh Fujinaga and colleagues at the University of California at San Francisco.
Fujinaga and coauthors found that a dominant-negative fusion protein, comprising mutant versions of hCycT1 and TAR (Cdk9), strongly inhibited HIV activity in human...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.